Design Therapeutics, Inc. (DSGN)
NASDAQ: DSGN · Real-Time Price · USD
3.880
-0.360 (-8.49%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Design Therapeutics Analyst Ratings
Total Analysts
2
Consensus Rating
Buy
Price Target
$8.00
Upside
+106.19%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Hold Reiterates $4 | Hold | Reiterates | $4 | +3.09% | Aug 6, 2024 |
| Piper Sandler | Piper Sandler | Hold → Buy Upgrades $6 → $12 | Hold → Buy | Upgrades | $6 → $12 | +209.28% | May 7, 2024 |
| RBC Capital | RBC Capital | Hold Reiterates $4 | Hold | Reiterates | $4 | +3.09% | Mar 20, 2024 |
| Wedbush | Wedbush | Hold Reiterates $5 | Hold | Reiterates | $5 | +28.87% | Mar 20, 2024 |
| RBC Capital | RBC Capital | Hold Maintains $7 → $4 | Hold | Maintains | $7 → $4 | +3.09% | Nov 14, 2023 |
| Wedbush | Wedbush | Buy → Hold Downgrades $6 | Buy → Hold | Downgrades | $6 | +54.64% | Aug 15, 2023 |
| SVB Leerink | SVB Leerink | Buy → Hold Downgrades $6 | Buy → Hold | Downgrades | $6 | +54.64% | Aug 15, 2023 |
| RBC Capital | RBC Capital | Buy → Hold Downgrades $23 → $7 | Buy → Hold | Downgrades | $23 → $7 | +80.41% | Aug 15, 2023 |
| RBC Capital | RBC Capital | Buy Maintains $24 → $23 | Buy | Maintains | $24 → $23 | +492.78% | May 10, 2023 |
| Wedbush | Wedbush | Buy Maintains $20 → $19 | Buy | Maintains | $20 → $19 | +389.69% | May 10, 2023 |
| Goldman Sachs | Goldman Sachs | Strong Sell → Hold Upgrades n/a | Strong Sell → Hold | Upgrades | n/a | n/a | May 4, 2023 |
| RBC Capital | RBC Capital | Buy Reiterates $24 | Buy | Reiterates | $24 | +518.56% | Mar 15, 2023 |
| SVB Leerink | SVB Leerink | Buy Maintains $30 → $22 | Buy | Maintains | $30 → $22 | +467.01% | Dec 9, 2022 |
| RBC Capital | RBC Capital | Buy Maintains $29 → $24 | Buy | Maintains | $29 → $24 | +518.56% | Dec 8, 2022 |
| Wedbush | Wedbush | Buy Maintains $21 → $26 | Buy | Maintains | $21 → $26 | +570.10% | Aug 9, 2022 |
| Wedbush | Wedbush | Buy Initiates $21 | Buy | Initiates | $21 | +441.24% | Jun 10, 2022 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.